The role of CD14 gene promoter polymorphism in tuberculosis susceptibility

Journal of Microbiology, Immunology and Infection

Volumn 46, Issue 3, 2013, Pages 158-163

  Ayaslioglu, Ergin ^a   Kalpaklioglu, Fusun ^a   Kavut, Ayse Baccioglu ^a   Erturk, Arzu ^b   Capan, Nermin ^b   Birben, Esra ^c  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b Ataturk Chest Disease and Thoracic Surgery Education and Research Hospital Ankara   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

CD14; Polymorphism; Soluble CD14; Tuberculosis

Indexed keywords

CD14 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFECTION SENSITIVITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD14; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; TUBERCULOSIS; TURKEY; YOUNG ADULT;

EID: 84879275034     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.05.008     Document Type: Article

References (32)

1. Anas A., van der Poll T., de Vos A.F. Role of CD14 in lung inflammation and infection. Crit Care 2010, 14:209.
2. Landmann R., Muller B., Zimmerli W. CD14, new aspects of ligand and signal diversity. Microbes Infect 2000, 2:295-304.
3. Pacheco E., Fonseca C., Montes C., Zabaleta J., Garcia L.F., Arias M.A. CD14 gene promoter polymorphism in different clinical forms of tuberculosis. FEMS Immunol Med Microbiol 2004, 40:207-213.
4. Ayaslioglu E., Tekeli E., Birengel S. Significant elevation of serum soluble CD14 levels in patients with brucellosis. Jpn J Infect Dis 2005, 58:11-14.
5. Landmann R., Zimmerli W., Sansano S., Link S., Hahn A., Glauser M.P., et al. Increased circulating soluble CD14 is associated with high mortality in Gram-negative septic shock. JInfect Dis 1995, 171:639-644.
6. Ayaslioglu E., Basar H., Duruyurek N., Kalpaklioglu F., Gocmen S., Erturk A., et al. Disseminated tuberculosis with lymphatic, splenic and scrotal abscesses: a case report. Cases J 2009, 2:6995.
7. Yim J.J., Selvaraj P. Genetic susceptibility in tuberculosis. Respirology 2010, 15:241-256.
8. Maliarik M.J., Iannuzzi M.C. Host genetic factors in resistance and susceptibility to tuberculosis infection and disease. Semin Respir Crit Care Med 2003, 24:223-228.
9. Bhatt K., Salgame P. Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol 2007, 27:347-362.
10. Arcaroli J., Fessler M.B., Abraham E. Genetic polymorphisms and sepsis. Shock 2005, 24:300-312.
11. Gibot S., Cariou A., Drouet L., Rossignol M., Ripoll L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med 2002, 30:969-973.
12. Haidari M., Hajilooi M., Rezazadeh M., Rafiei A., Alavi S.A., Keramat F. Polymorphism in the promoter region of the CD14 gene and susceptibility to brucellosis. Immunol Invest 2006, 35:239-245.
13. Klein W., Tromm A., Griga T., Fricke H., Folwaczny C., Hocke M., et al. A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol 2002, 37:189-191.
14. Baldini M., Lohman I.C., Halonen M., Erickson R.P., Holt P.G., Martinez F.D. A Polymorphism in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999, 20:976-983.
15. Rupp J., Goepel W., Kramme E., Jahn J., Solbach W., Maass M. CD14 promoter polymorphism -159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes. Genes Immun 2004, 5:435-438.
16. Mohamed A.J., DuPont H.L., Flores J., Palur H., Nair P., Jiang Z.D., et al. Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with bacterial diarrhea in US and Canadian travelers to Mexico. Clin Infect Dis 2011, 52:1332-1341.
17. Rosas-Taraco A.G., Revol A., Salinas-Carmona M.C., Rendon A., Caballero-Olin G., Arce-Mendoza A.Y. CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis. J Infect Dis 2007, 196:1698-1706.
18. Kang Y.A., Lee H.W., Kim Y.W., Han S.K., Shim Y.S., Yim J.J. Association between the -159C/T CD14 gene polymorphism and tuberculosis in a Korean population. FEMS Immunol Med Microbiol 2009, 57:229-235.
19. Buyukoglan H., Gulmez I., Kelestimur F., Kart L., Oymak F.S., Demir R., et al. Leptin levels in various manifestations of pulmonary tuberculosis. Mediators Inflamm 2007 2007, 648-659.
20. Britton W.J., Fernando S.L., Saunders B.M., Sluyter R., Wiley J.S. The genetic control of susceptibility to Mycobacterium tuberculosis. Novartis Found Symp 2007, 281:79-89.
21. Sutherland A.M., Walley K.R., Russell J.A. Polymorphisms in CD14, mannose-binding lectin, and toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 2005, 33:638-644.
22. Agnese D.M., Calvano J.E., Hahm S.J., Coyle S.M., Corbett S.A., Calvano S.E., et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J Infect Dis 2002, 186:1522-1525.
23. Jessen K.M., Lindboe S.B., Petersen A.L., Eugen-Olsen J., Benfield T. Common TNF-alpha, IL-1 beta, PAI-1, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis. BMC Infect Dis 2007, 7:108.
24. Korbel D.S., Schneider B.E., Schaible U.E. Innate immunity in tuberculosis: myths and truth. Microbes Infect 2008, 10:995-1004.
25. Lawn S.D., Labeta M.O., Arias M., Acheampong J.W., Griffin G.E. Elevated serum concentrations of soluble CD14 in HIV- and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment. Clin Exp Immunol 2000, 120:483-487.
26. Takeshita S., Nakatani K., Tsujimoto H., Kawamura Y., Kawase H., Sekine I. Increased levels of circulating soluble CD14 in Kawasaki disease. Clin Exp Immunol 2000, 119:376-381.
27. Nockher W.A., Wigand R., Schoeppe W., Scherberich J.E. Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin Exp Immunol 1994, 96:15-19.
28. Burgmann H., Winkler S., Locker G.J., Presterl E., Laczika K., Staudinger T., et al. Increased serum concentration of soluble CD14 is a prognostic marker in Gram-positive sepsis. Clin Immunol Immunopathol 1996, 80:307-310.
29. Juffermans N.P., Verbon A., van Deventer S.J.H., Buurman W.A., van Deutkom H., Speelman P., et al. Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J Infect Dis 1998, 178:1839-1842.
30. Hoheisel G., Zheng L., Teschler H., Striz I., Costabel U. Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis. Chest 1995, 108:1614-1616.
31. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
32. Thuong N.T., Hawn T.R., Thwaites G.E., Chau T.T., Lan N.T., Quy H.T., et al. A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun 2007, 8:422-428.